SVB Leerink Downgrades Moderna (MRNA) to Underperform
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $144.74 -0.56%
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar downgraded Moderna (NASDAQ: MRNA) from Market Perform to Underperform with a price target of $93.00 (from $111.00).
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $147.57 yesterday.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- CMS Energy (CMS) PT Lowered to $77 at BMO Capital
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
